Comments
Researchers at Oxford are bracing for the production of advanced versions of the Covid-19 vaccine that can fight the emerging and more contagious Covid-19 variants, Telegraph reported.
The research team that developed vaccines from Oxford and AstraZeneca Plc is now reconfiguring their technology to produce potent doses of vaccine against emerging mutations from the UK, South Africa, Brazil, among others.
The scientists are now estimating how quickly they could reconfigure their ChAdOx vaccine platform, the report said.
Also read: Bharat Biotech to approach WHO for Covaxin pre-qualification
An Oxford spokesman said to Telegraph that the university is monitoring the impact of new variants on vaccine immunity. They will then evaluate the processes that can be employed for the rapid production of adjusted Covid-19 vaccines, if necessary.
Meanwhile, UK Prime Minister Boris Johnson said on Wednesday that the country’s medicine regulator will be able to assess and give approval to new versions of the vaccine to mitigate the spread of new strains, as per media reports.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.